Population
Factor VIII (FVIII) protein variants
Comparison
Generation of FVIII variants with a disulfide… vs Wild-type (WT) FVIII
Design
Preclinical
Authors
Loading...
These FVIII variants remain preclinical; leaves open potential for engineered hemophilia therapies pending further validation.
Altering contacts at the A1-C2 junction of Factor VIII by covalent modification or increasing hydrophobicity functionally enhances FVIII thermal stability.
Wakabayashi et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: